Sagiment Biosciences Stock Quote SGMT - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.42

Bid

3.21

Ask

3.57

Volume

239,160

3.29 Day's Range 3.5553

2.13 52 Week Range 20.71

Market Cap

103.945M

Previous Close

3.40

Open

3.47

Last Trade

3.4

Last Trade Time

Financial Volume

$ 809,415

VWAP

3.3844

Average Volume (3m)

491,569

Shares Outstanding

30,393,397

Dividend Yield

PE Ratio

-3.75

Earnings Per Share (EPS)

-0.92

Revenue

Net Profit

-27.88M

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment ... Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.sagimet.com

Headquarters

Camden, Delaware, USA

Founded

1970

Sagiment Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SGMT. The last closing price for Sagiment Biosciences was $3.40. Over the last year, Sagiment Biosciences shares have traded in a share price range of $ 2.13 to $ 20.71.

Sagiment Biosciences currently has 30,393,397 shares outstanding. The market capitalization of Sagiment Biosciences is $103.34 million. Sagiment Biosciences has a price to earnings ratio (PE ratio) of -3.75.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.32	10.3225806452	3.1	3.5553	2.95	267384	3.19436376	CS
4	0.02	0.588235294118	3.4	3.71	2.78	398167	3.18655856	CS
12	-1.2	-25.974025974	4.62	5.7	2.78	491569	4.28910796	CS
26	-9.45	-73.4265734266	12.87	13.24	2.78	830247	6.05098259	CS
52	-12.52	-78.5445420326	15.94	20.71	2.13	641019	9.3042785	CS
156	-12.08	-77.935483871	15.5	20.71	2.13	627304	9.36886058	CS
260	-12.08	-77.935483871	15.5	20.71	2.13	627304	9.36886058	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M